EyeConic: Qualification for Cone-Optogenetics
ConditionRetinal Dystrophies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorInstitute of Molecular and Clinical Ophthalmology Basel
About this trial
This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.
Eligibility criteria
Qualifiers
Diagnosis of generalized IRD
Low vision as defined as visual acuity worse or equal to 0.05 (or 20/400) in the study eye
Availability of macular optical coherence tomography (OCT)
Normal ophthalmic findings
Disqualifiers
Other eye diseases with a significant effect on vision or retinal structure
Extraocular disease affecting retinal structure such as neurodegenerative diseases
Trial design
Treatments tested in this trial
- Optical coherence tomography (OCT)
Treatment groups
1,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov